After an evaluation of 800,000 doses of pentavalent rotavirus vaccinations in U.S. infants, researchers reported in the February 8 issue of JAMA that there is no increased risk of intussusception after vaccination, despite some previous data indicating that those infants who received the vaccine...
ROTATEQ(R) (Rotavirus Vaccine, Live, Oral, Pentavalent), Merck's vaccine for rotavirus gastroenteritis in infants and children, received the Prix Galien USA 2010 Award for Best Biotechnology Product, Merck announced last week. "We are honored that Merck's long-term commitment to the discovery...
GlaxoSmithKline (NYSE: GSK) announced that the Food and Drug Administration (FDA) has determined that U.S. healthcare practitioners can resume the use of Rotarix® (Rotavirus Vaccine, Live, Oral), effective immediately. This action supersedes the FDA's recommendation from March 22, 2010 and...
The WHO on Monday advised developing countries to continue administering GlaxoSmithKline's Rotarix vaccine - which offers protection to children against the diarrhea-causing rotavirus - after the FDA advised doctors in the U.S. to temporarily stop using the vaccine following the discovery that...
Rotavirus is the leading cause of severe, acute gastroenteritis among infants and young children throughout the world and is responsible for an estimated 527,000 deaths among children under five each year. More than 90% of childhood deaths attributed to rotavirus infection occur in developing...
U.S. H1N1 Response Highlights Need For Improvements "[D]espite the tireless efforts of public health and health-care workers, America's experience with H1N1 shows that the nation is not prepared to deal with a flu pandemic," former Democratic Senator Bob Graham and former Republican...